Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 118 participants.
Also called NCT04040959
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 118 participants
- Sponsor
- Registry
-
NCT04040959
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04040959. Randomized; quadruple masking; primary purpose treatment. Start 2019-11-19 (actual); primary completion 2026-07-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- Condition
- Vascular Diseases
- Condition
- Kidney Disease
- Condition
- Blood Pressure
- Condition
- Oxidative Stress
- Intervention (Drug)
- Nicotinamide riboside
- Lead sponsor
- University of Colorado, Denver
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct04040959- Content hash
fc08e2b963fb1d460c7064f86a849963d88fc92b13cbb8d9fcab82ff3366f3aa